The tumor then recruits new blood vessels by secreting angiogenic activators such as vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF), and tumor necrosis factor alpha (TNF-a)14–18. The gene discussed is FGF2; the disease is neoplasm.